Fmoc-Asp-Ome structure
|
Common Name | Fmoc-Asp-Ome | ||
---|---|---|---|---|
CAS Number | 145038-52-4 | Molecular Weight | 369.368 | |
Density | 1.3±0.1 g/cm3 | Boiling Point | 609.7±55.0 °C at 760 mmHg | |
Molecular Formula | C20H19NO6 | Melting Point | N/A | |
MSDS | N/A | Flash Point | 322.5±31.5 °C |
Use of Fmoc-Asp-OmeFmoc-Asp-OMe is an aspartic acid derivative[1]. |
Name | (S)-3-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-4-methoxy-4-oxobutanoic acid |
---|---|
Synonym | More Synonyms |
Description | Fmoc-Asp-OMe is an aspartic acid derivative[1]. |
---|---|
Related Catalog | |
In Vitro | Amino acids and amino acid derivatives have been commercially used as ergogenic supplements. They influence the secretion of anabolic hormones, supply of fuel during exercise, mental performance during stress related tasks and prevent exercise induced muscle damage. They are recognized to be beneficial as ergogenic dietary substances[1]. |
References |
Density | 1.3±0.1 g/cm3 |
---|---|
Boiling Point | 609.7±55.0 °C at 760 mmHg |
Molecular Formula | C20H19NO6 |
Molecular Weight | 369.368 |
Flash Point | 322.5±31.5 °C |
Exact Mass | 369.121246 |
PSA | 101.93000 |
LogP | 3.93 |
Vapour Pressure | 0.0±1.8 mmHg at 25°C |
Index of Refraction | 1.596 |
Storage condition | 2~8°C |
Hazard Codes | Xi |
---|---|
HS Code | 2924299090 |
HS Code | 2924299090 |
---|---|
Summary | 2924299090. other cyclic amides (including cyclic carbamates) and their derivatives; salts thereof. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:30.0% |
(3S)-3-{[(9H-Fluoren-9-ylmethoxy)carbonyl]amino}-4-methoxy-4-oxobutanoic acid (non-preferred name) |
(3S)-3-{[(9H-Fluoren-9-ylmethoxy)carbonyl]amino}-4-methoxy-4-oxobutanoic acid |
(2S)-2-{[(9H-Fluoren-9-ylmethoxy)carbonyl]amino}-4-methoxy-4-oxobutanoic acid |
L-Aspartic acid, N-[(9H-fluoren-9-ylmethoxy)carbonyl]-, 1-methyl ester |
(3S)-3-(9H-fluoren-9-ylmethoxycarbonylamino)-4-methoxy-4-oxobutanoic acid |
L-Aspartic acid, N-[(9H-fluoren-9-ylmethoxy)carbonyl]-, 4-methyl ester |
Fmoc-Asp-Ome |